Search
The transition of Value Research Online has been postponed to take care of some user concerns.
You are welcome to try out the new site at https://beta.valueresearchonline.com

Granules India

Sector: Healthcare | Industry: Drugs & Pharma
R 121.50 -5.65  | -4.44% 43.03% 10.19 3,090.38
NSE Price: Dec 06, 15:58 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Dec 06, 15:58 121.50 -5.65 -4.44% 127.00 127.15 2,665,285 120.55 - 130.00
BSE Dec 06, 2019 121.55 -5.35 -4.22% 127.55 126.90 120,415 120.20 - 130.00
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
GET STOCK UPDATES FROM VALUE RESEARCH IN YOUR INBOX
6M Average Volume: 966,292 P/B: 1.82 NSE Code: GRANULES
52-Week Range: R 79.15 - 135.90 Dividend Yield: 0.82% BSE Code: 532482
TTM EPS: R 11.93 Book Value: R 66.89 Face Value: R 1
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 37
Price Graph
  • Procter & Gamble Health (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Value Research Stock Advisor now has 37 stock recommendations and new ones are added every month.
Thousands of our members are using the current market conditions to buy great stocks at low prices.

Membership of this premium service is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Granules India 35.58 2.27 31.48 43.25 2.72 9.55 29.25
S&P BSE Small Cap* -8.51 -0.49 7.68 -6.16 3.56 3.23 5.53
S&P BSE Healthcare* -3.24 2.16 4.31 -2.91 -4.93 -2.03 10.33
Company's return has been calculated on basis of BSE's price.
As on Dec 06, 2019
*As on Dec 05, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 35.29 18.86 15.77
Net Profit 60.94 14.54 20.06
EPS 78.01 17.89 20.18
Book Value 16.73 26.94 28.03
Average
Operating Margin 18.02 19.03 18.86
Net Margin 8.14 8.29 8.21
Return on Networth 13.32 14.05 17.79
Return on Investment 12.71 13.46 15.87
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 17.51 20.43 14.06
Operating Profit 26.39 45.42 53.06
Net Profit 65.88 102.81 112.68
EPS 15.08 58.91 49.59
TTM
Revenue 4.90 30.34 11.44
Operating Profit 10.72 53.45 19.65
Net Profit 23.32 94.93 36.85
EPS 13.26 80.96 28.30
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Granules India 3,090.38 2,539.90 256.81 10.04 13.32 1.82 10.19
Astrazeneca Pharma India 6,631.63 818.54 74.85 8.97 20.03 20.12 88.60
Procter & Gamble Health 7,064.70 894.23 835.89 14.21 73.79 9.06 52.71
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Oct 25, 2019 Stefan Lohle Corredor  Sell Market 16,131 124.20 20.03
May 24, 2019 Stefan Lohle Corredor  Sell Market 32,000 110.70 35.42
Mar 25, 2019 Stefan Lohle Corredor  Sell Market 18,400 110.55 20.34
Mar 18, 2019 Stefan Lohle Corredor  Sell Market 13,469 112.85 15.20
Mar 08, 2019 Krishna Prasad Chigurupati  Sell Block Deal 5,000,000 111.30 5,565.00
Fund Houses invested in the stock
Fund Sep-19 Jun-19 Mar-19 Dec-18 Sep-18
Motilal Oswal Mutual Fund 0.002 - - - -
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Granules India Ltd.

Address: Second Floor, Block No 3, My Home Hub, Madhapur, Hyderabad, Telangana - 500081 | Phone: 040-30660000 | Fax: 040-23115145

Email: [email protected]

Website: www.granulesindia.com

Registrar & Transfer Agent: Karvy Fintech Pvt Ltd.-(Karvy Computuershare Pvt Ltd.)

Address: Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001, Karvy Selenium Tower B, Plot 31-32, Gachibowli,Financial District, Nanakramguda | Phone: 91-040-67161500 | Fax: 91-040-23001153

Email: [email protected]

Website: www.karvy.com

Essential checks
Altman Z-Score
3.41
Piotroski F-Score
8
Modified C-Score
1
5-Years Price to Earnings
10.19
5-Years Price to Book
1.82
Earnings Yield
EBIT / Enterprise value
9.47%
PEG
Price / Earnings to growth ratio
0.44
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,652.10 -2.42%
Eris Lifesciences R476.35 +7.39%
FDC R206.25 +4.14%
JB Chemicals & Pharma R403.25 +0.41%
Laurus Labs R340.20 -1.05%
Procter & Gamble Health R4,255.45 -1.09%
Strides Pharma Science R378.05 -0.49%
Sun Pharma Adv. Research R153.80 -1.51%
Suven Life Sciences R279.55 +2.46%
Wockhardt R244.15 -2.36%
As on Dec 06, 15:59